Learning outcomes
By the end of this lesson you should be able to: define a depressive episode by its core and somatic symptoms, its duration and its severity bands; distinguish depressive disorder from grief, adjustment disorder, dysthymia, depressive pseudodementia and depressive symptoms caused by medical illness or medication; apply the two screening questions and the PHQ-9 appropriately; assess suicide risk in terms of ideation, plan, intent, means and protective factors; and outline the stepped management of depression including psychological therapy, antidepressant selection and administration, electroconvulsive therapy and risk-aware monitoring.
Prerequisites
Lesson 8 (Bipolar disorder). Screening for past mania or hypomania is a prerequisite for safely treating any depressive episode, and this lesson assumes it.
The big idea
Depression is the commonest reason a patient of any age consults a doctor and one of the largest causes of disability worldwide. The single most useful shift in thinking is to separate symptom, syndrome and diagnosis. Low mood is a symptom everyone experiences; a depressive episode requires duration, severity and impact; and a depressive disorder requires exclusion of other causes and of bipolarity. Keep those three apart and you will neither over-diagnose misery nor under-diagnose illness.
One further feature deserves emphasis because it is frequently misattributed to weakness or laziness. In depression, the difficulty is not that the patient will not act but that the machinery of initiating action is impaired: reward anticipation is blunted, effort is subjectively more costly, and concentration fails at the point of use. The clinical description is that of withdrawal and inactivity, and patients are often blamed for it — by employers, by families, and occasionally by clinicians.
The symptoms
| Domain | Symptoms | How to elicit it |
|---|---|---|
| Core | Persistent low mood or irritability; loss of interest and pleasure | 'In the past two weeks, how often have you been bothered by feeling down, depressed or hopeless?' and '...by little interest or pleasure in doing things?' |
| Energy | Fatigue and loss of energy; activities feel disproportionately effortful | 'Do everyday tasks take more effort than they used to?' |
| Biological | Insomnia with early morning waking or, less commonly, hypersomnia; appetite and weight change; reduced libido; diurnal variation with a worse morning | 'What time do you wake, and how do you feel then compared with the evening?' |
| Cognitive | Impaired concentration and indecisiveness; poor memory; slowed thinking | 'Have other people noticed a change in how much you can take in?' |
| Affective-cognitive | Guilt, worthlessness, hopelessness, low self-confidence, self-criticism | 'When you make a mistake, what do you think it says about you?' |
| Suicidality | Recurrent thoughts of death, suicidal ideation, plans, prior attempts | 'Have you had thoughts that you would be better off dead, or of hurting yourself?' |
| Psychotic | Mood-congruent delusions of guilt, worthlessness, poverty, nihilism or persecution; auditory voices of condemnation | A psychotic depression is severe by definition and requires urgent treatment |
The thresholds are the part that must be exact. ICD-11's episode requires at least two weeks with depressed mood, loss of interest or reduced energy plus at least four further symptoms from the list; mild (four symptoms), moderate (five or six) and severe (seven or more, with or without psychosis) are the conventional severity bands, classified by symptom count and functional impact. DSM-5 requires five or more symptoms over the same two weeks, including one of the two core symptoms, with clinically significant distress or impairment, and with exclusions for substances, medical illness, grief and bipolarity.
NoteDysthymia, now persistent depressive disorder, describes at least two years of low mood with additional symptoms that do not reach full episode criteria. It is not a mild form of the same illness; it is a distinct, chronic, early-onset pattern with a higher risk of later major depressive episodes and a poorer response to short treatments. Double depression — a major episode superimposed on persistent depressive disorder — is common and often missed, because both patient and clinician discount the chronic background as personality.
Differential diagnosis
| Condition | What distinguishes it | The action it requires |
|---|---|---|
| Normal grief and bereavement reaction | Waves of painful yearning focused on the deceased, preserved self-esteem, capacity for humour and pleasure, and doubt rather than guilt about what happened | Support and monitoring; not a diagnosis unless it persists beyond a few months or meets episode criteria, and grief is a risk factor for later depression rather than an alternative to it |
| Adjustment disorder with depressed mood | Emerges within three months of an identifiable stressor and does not meet full episode criteria | Problem-solving, counselling and monitoring; resolve the stressor where possible |
| Bipolar depression | A history of mania or hypomania; early onset, atypical features, psychomotor retardation and postpartum onset are pointers | Screen with the two questions of Lesson 8 before prescribing; bipolar depression is treated with quetiapine, lamotrigine or lithium rather than antidepressant monotherapy |
| Substance- or medication-induced depressive disorder | Temporal relation to alcohol, cannabis, stimulant withdrawal, opioids, corticosteroids, interferon alfa, isotretinoin, varenicline or antihypertensives | Withdraw, substitute or reduce the offending agent where possible and reassess |
| Depression due to a medical condition | Hypothyroidism, anaemia, obstructive sleep apnoea, vitamin B12 or folate deficiency, Cushing syndrome, Parkinson's disease, dementia, cerebrovascular disease, malignancy, Addison's disease, chronic infection | Check thyroid function, full blood count, B12, folate, glucose, calcium, renal and liver function, and consider further testing on history |
| Delirium and dementia | Acute change with impaired attention and fluctuating consciousness in delirium; insidious multi-domain decline with preserved attention early in dementia | Delirium is a medical emergency; depressive pseudodementia responds to the treatment of the depression and is a trap made by not asking about mood |
| Anxiety disorders | Worry, tension and restlessness dominate; depression is commonly comorbid and should be diagnosed alongside, not instead of | Treat both; comorbidity is the rule and worsens prognosis |
| Premenstrual dysphoric disorder and perimenopausal depression | Cyclical mood symptoms, irritability and tension confined to the luteal phase | A symptom diary over two or three cycles; treatment may be cyclical |
Watch outAlways exclude bipolar disorder and always exclude organic disease. A woman in her twenties with three depressive episodes and antidepressant-induced agitation needs the mania question asked. A man of sixty with new-onset depression, weight loss and fatigue needs a clinical examination, not a prescription.
Special presentations
| Presentation | Phenomenology | Clinical importance |
|---|---|---|
| Melancholic depression | Pervasive anhedonia, non-reactive mood, early morning waking, marked psychomotor retardation or agitation, weight loss, excessive guilt | When severe, the physical treatments — electroconvulsive therapy and antidepressants — outperform psychotherapy alone |
| Atypical depression | Mood reactivity, hypersomnia, hyperphagia with weight gain, leaden paralysis of the limbs, long-standing interpersonal rejection sensitivity | Historically linked with monoamine oxidase inhibitors, but SSRIs are used in practice; the pattern often begins early and persists |
| Psychotic depression | Mood-congruent delusions of guilt, worthlessness, poverty or nihilism, or depressive auditory hallucinations | Requires combined antidepressant-antipsychotic treatment or electroconvulsive therapy; antipsychotic alone is inadequate |
| Postnatal depression | Onset within weeks to months after delivery, with anxiety, intrusive thoughts of harm to the infant and exhaustion | Treat the mother's illness and assess the infant's safety and development; peripartum screening is a normal part of maternity care |
| Depression with anxiety and irritability | Tension, restlessness and irritability alongside low mood; commoner in men, adolescents and older adults | Do not discount irritability: it is a depressive symptom in its own right and is often the presenting complaint in men |
| Seasonal affective disorder | Recurrent winter episodes with hypersomnia, hyperphagia and carbohydrate craving | Bright light therapy has a specific evidence base here |
Screening and suicide risk assessment
The two screening questions derive from the nine items of the PHQ-9: over the last two weeks, how often have you been bothered by (a) little interest or pleasure in doing things, and (b) feeling down, depressed or hopeless? A yes to either triggers the full PHQ-9, which is a severity instrument with cut points of 5, 10, 15 and 20 for mild, moderate, moderately severe and severe. Item nine asks about thoughts of being better off dead or of hurting oneself, and a positive response must be followed by direct assessment, not by a formula.
| Suicide risk domain | Static factors | Dynamic factors | Protective factors |
|---|---|---|---|
| History | Previous attempt — the strongest single predictor; family history of suicide | Current depressive episode, hopelessness, recent discharge from hospital | Good social support, dependants, religious objection, reasons for living stated by the patient |
| Access | Occupation or home with means (firearms, medications, high buildings) | Intoxication, which disinhibits and impairs judgement | Restricting means, storing medications more safely, removing firearms |
| Intent and plan | — | Specificity, lethality and timing of the plan; any preparation made | Future orientation; the patient's stated reasons and the therapeutic relationship |
| Demography and context | Male sex (completed suicide), older age, chronic pain, recent bereavement, unemployment | Isolation, recent relationship breakdown, financial crisis, alcoholism | Engagement with services, and a treatment plan the patient accepts |
Watch outAsk directly, and do not believe the myth that asking plants the idea. A patient is not made suicidal by a question, and an unasked question leaves the risk unassessed. Ask about ideation first, then plan, then intent, then means, then protective factors. Record the patient's own words — 'I want to die' is a different entry from 'I would not mind not waking up'. Finally, avoid the phrase 'committed suicide', which implies criminality, and use 'died by suicide'.
Suicide risk is elevated early in treatment, in the weeks after diagnosis, and shortly after discharge from hospital. It is concentrated in patients with depression combined with hopelessness, insomnia and substance misuse. A safety plan — written, with the patient, naming warning signs, coping strategies, people to contact, and means restriction — reduces subsequent suicidal behaviour and is recommended alongside risk assessment rather than instead of it.
Management
Care is stepped: the intensity of treatment is matched to severity and response, and the stepping is both up and down. Mild depression is treated with guided self-help, structured physical activity, behavioural activation, computerised or group cognitive therapy, and problem-solving therapy; watchful waiting for two weeks is reasonable for a first presentation. Moderate depression is treated with individual cognitive therapy or interpersonal therapy. Severe and psychotic depression requires combined pharmacotherapy, sometimes electroconvulsive therapy, and often admission.
| Intervention | Indication | Evidence and notes |
|---|---|---|
| CBT | Moderate and severe depression; relapse prevention | The most extensively evidenced psychological treatment; 12-16 sessions; equal in effect to medication for milder episodes and superior in relapse prevention |
| Interpersonal therapy | Depression related to loss, role transition, role dispute and social isolation | Twelve to sixteen sessions; addresses the interpersonal context that precipitated the episode |
| Behavioural activation | Depression with withdrawal and low activity | Simple to deliver, highly effective, and the mechanism of relief is increased contact with reinforcement — as predicted by Lesson 2 |
| Problem-solving therapy | Multiple life problems; low educational attainment; older adults | Structured and practical, and superior to placebo in older adults with executive impairment |
| Mindfulness-based cognitive therapy | Relapse prevention in recurrent depression | Reduces relapse in patients with three or more previous episodes, roughly halving it, at the cost of intensive group practice |
| Psychodynamic and counselling approaches | Depression with chronic interpersonal themes | Effective for a substantial minority, but the evidence is weaker and the duration longer |
| Physical activity and sleep regulation | All severities, as adjuncts | Exercise has moderate efficacy and improves physical comorbidity, which is itself a cause of excess mortality |
Antidepressants are first-line for moderate and severe depression and are usually unnecessary for mild. Selective serotonin reuptake inhibitors (sertraline, escitalopram, fluoxetine) are the usual first choice on tolerability; serotonin and noradrenaline reuptake inhibitors (venlafaxine, duloxetine) are second-line and carry greater withdrawal burden and blood pressure effects. The practical rules governing their use are the following:
| Rule | Content | Rationale |
|---|---|---|
| Latency | A response takes two to four weeks, and much longer for full remission — do not judge before four weeks, and do not abandon before six to eight weeks at an adequate dose | The monoamine rise is immediate but the therapeutic effect depends on downstream adaptation |
| Monitoring | Weekly review for the first weeks in patients at risk of suicide, particularly the under-25s | Regulatory agencies have warned of a small increase in suicidal ideation early in treatment in this age group |
| Duration | Continue for at least six months after remission, and two years or longer for recurrent or severe episodes | Premature withdrawal is a principal cause of relapse, and discontinuation is the commonest error |
| Switching | After failure, switch class (SSRI to SNRI or mirtazapine) or augment with lithium, aripiprazole, quetiapine or thyroid hormone | Non-response to one agent predicts response to another rather than to none |
| Discontinuation | Taper over weeks to months; expect FINISH symptoms (flu-like, insomnia, nausea, imbalance, sensory disturbance, hyperarousal) | Confident reassurance before starting that the drug can be tapered prevents much avoidable alarm |
| Adverse effects | Hyponatraemia, particularly in older adults; gastrointestinal upset and sexual dysfunction; bleeding risk with non-steroidal anti-inflammatory drugs; serotonin syndrome with triptans and with tramadol or linezolid; QT prolongation with citalopram | Discuss these before prescribing: an informed patient adheres better, and the hyponatraemia risk in the elderly is often forgotten |
Watch outDo not tell a patient that they will become dependent. Antidepressants are not addictive in the pharmacological sense: there is no craving and no dose escalation. There is a physiological adaptation on stopping, which is why tapering is used, and conflating that with addiction is both inaccurate and a cause of avoidable non-adherence. This distinction is worth making explicitly in the first consultation.
Electroconvulsive therapy is the most effective treatment available for severe depression, and it is specifically indicated when there is psychotic depression, catatonia, refusal of food or drink, high immediate suicide risk, or failure of other treatment. Six to twelve treatments are typically given, and the main adverse effects are transient confusion and retrograde amnesia for the period around treatment. It is a treatment of choice, not a last resort, and the stigma that surrounds it derives from historical practice rather than from modern, consent-based, monitored electroconvulsive therapy.
Refractory depression is treated with a combination of electroconvulsive therapy, repetitive transcranial magnetic stimulation, ketamine or esketamine in specialist services with monitoring for dissociation and blood pressure, and, less commonly, vagus nerve stimulation. Finally, the social determinants of relapse — unemployment, debt, isolation and carer burden — must be addressed alongside the symptoms, because they are causal, as Lesson 6 established.
Common mistakes
Watch outPrescribing an antidepressant for a patient whose low mood is a normal reaction to bereavement, redundancy or a new disability. In the right situation that is not unkind, but it converts an understandable reaction into a medical problem, and it delays the problem solving that the situation actually requires. Ask whether the symptoms exceed the reaction, and if they do not, treat the problem.
Watch outConfounding the hypothyroid presentation. Depression is a common presentation of hypothyroidism and of anaemia, and thyroid function, a full blood count, B12 and folate are as much a part of the first assessment as the mental status examination. Weight loss and fatigue in an older patient should prompt a physical examination before a prescription.
Watch outAssuming that a patient with a chronic disease who is depressed needs only reassurance, or conversely that someone with a chronically gloomy manner cannot be depressed. Depression is common in chronic physical disease, worsens its outcome, and responds to treatment. And a low-grade, lifelong, low mood is persistent depressive disorder — it is neither a character trait nor a mild episode, and it is often missed because both patient and clinician have discounted it as personality.
Check your understanding
A 62-year-old woman has had six months of low mood, anhedonia and 8 kg weight loss with early morning waking and profound guilt about a trivial decision she made at work. What is the diagnosis, the differential, and the main safety consideration?
How would you ask about suicidal ideation without leading the patient?
A patient improved on sertraline six months ago and now asks to stop immediately. What is your advice?
Summary and next
A depressive episode is two weeks of depressed mood and anhedonia with associated cognitive, somatic and suicidal symptoms, graded by count and impact, and distinguished from grief, adjustment disorder, bipolar depression and organic disease. Screening uses two questions and a nine-item severity measure; suicide risk is assessed directly for ideation, plan, intent, means and protective factors. Management is stepped, psychological therapies carry the relapse-prevention advantage, antidepressants require adequate dose, duration and monitoring, and electroconvulsive therapy remains the most effective treatment for severe and psychotic depression.
Next: anxiety, phobia and obsessive-compulsive disorder. You will apply the two-factor conditioning model of Lesson 2 to the commonest disorders in practice, and see why exposure and response prevention, rather than reassurance, is the active ingredient.
Multiple choice
Which pair of symptoms are the two core symptoms of a depressive episode?
Which feature most strongly suggests that a grief reaction is not a depressive episode?
Which blood test is most important at a first presentation of depression in an older adult?
A patient with severe depression and delusions of worthlessness is best treated with which of the following?
Which statement about antidepressant withdrawal is correct?